MedTrace Logo

Detection of Propofol in Exhaled Breath

NCT02214394 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2014-08-12

No results posted yet for this study

Summary

This study involves the use of an experimental device which will measure how much propofol is present in your exhaled breath during surgery compared to how much is in your blood. The study results will look at whether the device is as accurate as conventional methods for measuring propofol levels during surgery.

Conditions

  • Healthy

Interventions

OTHER

High-performance liquid chromatography Analysis

Blood samples will be collected for HPLC analysis to compare with the breath samples.

DEVICE

SMART Device

Breath collection for GC-MS analysis to compare with Blood collection.

Sponsors & Collaborators

  • National Institute of General Medical Sciences (NIGMS)

    collaborator NIH

  • Xhale Assurance

    lead INDUSTRY

Principal Investigators

  • Donn M Dennis, M.D., F.A.H.A. · Xhale, Inc.

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2014-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02214394 on ClinicalTrials.gov